English, , 506kb
In this issue: details on the Health Ministerial meeting, Balancing quality and privacy in health care, Fit not Fat in the media, Health challenges after the crisis, Making Reform Happen, and our new publications.
This book examines the potential economic impacts of nanotechnology, how companies are using nanotechnology for innovation, and what the key challenges in its commercialisation might be.
This biotechnology global forum, "Delivering Global Promise Through the Life Sciences" underlined how the latest social science research into genomics science can help inform key global economic and policy decisions.
The OECD Employment, Labour and Social Affairs Directorate has launched in September 2008 a series of seminars open to both external and internal speakers. It is intended to be an informal forum for discussion of policy-oriented empirical research work among policy-makers, academics and OECD staff.
Mental illness is a growing problem in society and is increasingly affecting productivity and well-being in the workplace. This project challenges some of the myths around mental health.
Too many workers leave the labour market permanently due to health problems or disability, and too few people with reduced work capacity manage to remain in employment. This is a social and economic tragedy common to virtually all OECD countries. It also raises an apparent paradox that needs explaining: Why is it that the average health status is improving, yet large numbers of people of working age are leaving the workforce to
English, , 319kb
This article published in The Lancet highlights the fact that the obesity epidemic is spreading to low-income and middle-income countries as a result of new dietary habits and sedentary ways of life, fuelling chronic diseases and premature mortality.
As a follow up to the Outlook on Industrial Biotechnology Workshop organised in January 2010, a workshop entitled “Building an Efficient Bio-Based Economy through Industrial Biotechnology” was held in St Petersburg.
For many of today’s new biomedical innovations, the distinctions between different forms of medical products such as drugs, diagnostics and devices no longer apply. Biomedicine also tends to realize its potential today through process innovation, even more than product innovation.
Driving while impaired by drugs – whether licit or illicit – has emerged as an important road safety issue. This report provides a state-of-the-art review of the role and impact of drugs in road accident risk. It reviews the legislation, deterrence and roadside detection practices in member countries as well as preventative measures to combat drug use while driving. It provides recommendations on strategies to adopt in addressing